When to Order Imaging for Evaluation of Nipple Discharge: ACR Appropriateness Decoded

A 42-year-old patient presents with spontaneous, unilateral, serosanguinous nipple discharge. Your next step is to determine the appropriate imaging workup. Do you start with a diagnostic mammogram, a targeted ultrasound, or both? In the evaluation of nipple discharge, selecting the correct initial imaging modality is crucial for timely diagnosis while avoiding unnecessary tests and radiation exposure. This article provides a clear, scannable guide to the American College of Radiology (ACR) Appropriateness Criteria for this common clinical presentation, helping you make evidence-based decisions for your patients.

What Does ACR Evaluation of Nipple Discharge Cover?

This ACR guideline focuses on the initial imaging workup for patients presenting with nipple discharge. The recommendations are stratified based on key clinical factors, including the patient’s age, gender identity, and, most importantly, the clinical characterization of the discharge as either physiologic or pathologic. Physiologic discharge is typically bilateral, non-spontaneous (occurs only with expression), involves multiple ducts, and is often milky or green-tinged. In contrast, pathologic discharge is typically unilateral, spontaneous, persistent, arises from a single duct, and is clear, serous, or bloody. These criteria apply to adult females, males, transfeminine, and transmasculine patients. The guidelines do not cover the evaluation of galactorrhea associated with hyperprolactinemia or breast abnormalities found on physical exam, such as a palpable mass, which have their own distinct evaluation pathways.

What Imaging Should I Order for Evaluation of Nipple Discharge? Recommendations by Clinical Scenario

The ACR provides specific imaging recommendations tailored to the clinical context. The approach varies significantly between physiologic and pathologic discharge and is further refined by patient age and demographics.

For any adult patient with physiologic nipple discharge, the ACR states that initial imaging is Usually not appropriate. This includes ultrasound, mammography, and MRI. Physiologic discharge is most often benign and related to hormonal fluctuations or fibrocystic changes, and imaging is generally not indicated in the absence of other suspicious clinical findings like a palpable lump or skin changes.

When the presentation is consistent with pathologic nipple discharge, the recommendations are stratified by age. For an adult male or female 40 years of age or older, both Diagnostic Mammography and Breast Ultrasound are rated as Usually appropriate. This dual-modality approach is recommended because mammography is effective at detecting suspicious calcifications and architectural distortion, while ultrasound excels at characterizing intraductal masses and guiding potential biopsies. The same recommendation applies to patients aged 30 to 39 years.

For younger patients with pathologic discharge, the guidance differs. In an adult female younger than 30 years of age, Breast Ultrasound is the only modality rated as Usually appropriate. Diagnostic mammography is rated Usually not appropriate in this age group, primarily due to the typically dense breast tissue which can limit mammographic sensitivity, as well as a desire to minimize radiation exposure in younger individuals. For an adult male younger than 30 years of age, however, both Diagnostic Mammography and Breast Ultrasound are considered Usually appropriate, reflecting a different risk profile and tissue composition.

The guidelines also provide specific recommendations for transgender patients. For an adult transfeminine (male-to-female) patient, regardless of age, with pathologic nipple discharge, both Diagnostic Mammography and Breast Ultrasound are rated as Usually appropriate. This approach acknowledges the development of glandular breast tissue secondary to hormone therapy.

Across all scenarios of initial evaluation for nipple discharge, more advanced or invasive procedures like ductography, MRI, PET, or biopsy are rated as Usually not appropriate as first-line imaging tests.

ACR Imaging Recommendations Table

Adult vs. Pediatric Evaluation of Nipple Discharge Imaging: Radiation Dose Tradeoffs

While this ACR topic primarily addresses adult presentations, the principles of radiation safety are particularly relevant when evaluating younger patients. The concept of ALARA (As Low As Reasonably Achievable) guides the preference for non-ionizing radiation modalities whenever clinically appropriate. For adult women under 30 with pathologic nipple discharge, breast ultrasound (0 mSv) is the sole “Usually appropriate” study, while mammography (which uses ionizing radiation) is deemed “Usually not appropriate.” This recommendation is driven by two factors: the higher density of breast tissue in younger women, which reduces the diagnostic sensitivity of mammography, and the greater lifetime risk associated with radiation exposure at a younger age. Although pediatric-specific variants for nipple discharge are not detailed in this guideline, the provided pediatric relative radiation level (RRL) indicators for modalities like ultrasound and MRI underscore the importance of selecting zero-radiation options for initial workups in the youngest patient populations when possible.

Imaging Protocol Details for Evaluation of Nipple Discharge

Once you’ve decided on the right study, the specific imaging protocol is critical for diagnostic accuracy. Our detailed protocol guides cover essential parameters like patient positioning, transducer selection for ultrasound, mammographic views, and contrast administration for advanced modalities. For the studies recommended in these guidelines, explore our in-depth resources:

• MRI Breast With and Without Contrast

Tools to Help You Order the Right Study

Navigating imaging guidelines can be complex. GigHz provides a suite of tools designed to support evidence-based clinical decisions, streamline ordering, and improve patient communication regarding radiation dose.

For clinical scenarios beyond the evaluation of nipple discharge, the Imaging Appropriateness Selector provides instant access to the full library of ACR guidelines, covering thousands of clinical variants across all organ systems.

To ensure the studies you order are performed correctly, the Imaging Protocol Library offers detailed, step-by-step protocols for hundreds of common and advanced imaging procedures, helping to standardize quality and diagnostic yield.

When discussing imaging options with patients, especially those involving radiation, the Radiation Dose Calculator is an invaluable resource for estimating cumulative radiation exposure and explaining dose in understandable terms.

Frequently Asked Questions

What is the clinical difference between physiologic and pathologic nipple discharge?

Physiologic nipple discharge is generally not concerning for malignancy. It is typically bilateral, involves multiple ducts, is non-spontaneous (requires compression to elicit), and the fluid is often milky, yellow, green, or brown. It is commonly associated with fibrocystic changes or hormonal fluctuations. Pathologic discharge is more suspicious and warrants an imaging workup. Its features are typically unilateral, spontaneous, persistent, from a single duct, and the fluid is clear (serous), bloody (sanguineous), or serosanguineous.

Why is mammography not the first-line imaging test for women under 30 with pathologic discharge?

In women under 30, breast tissue is often significantly denser than in older women. This dense glandular tissue can appear white on a mammogram, potentially obscuring an underlying mass, which also appears white. This reduces the sensitivity of mammography in this population. Ultrasound, which is not limited by breast density, is a more effective initial tool. Additionally, clinicians aim to minimize cumulative radiation exposure in younger patients, making zero-radiation ultrasound the preferred first step.

Is breast MRI ever used as a first-line test for nipple discharge?

No, according to the ACR Appropriateness Criteria for initial evaluation, breast MRI (with or without contrast) is rated as “Usually not appropriate” for all clinical variants of nipple discharge. While MRI is a highly sensitive modality for detecting breast cancer, it is typically reserved as a problem-solving tool if mammography and ultrasound are inconclusive or negative but clinical suspicion remains high, or for preoperative planning after a cancer diagnosis.

How do the recommendations for transfeminine patients on hormone therapy differ?

The ACR guidelines recommend that adult transfeminine patients with pathologic nipple discharge undergo both diagnostic mammography and breast ultrasound, regardless of their age. This recommendation is similar to that for cisgender women aged 30 and older. The rationale is that estrogen therapy induces the development of lobular and ductal breast tissue, making their risk profile and imaging needs different from those of cisgender men and more aligned with those of cisgender women.

What is ductography and why is it rated ‘Usually not appropriate’?

Ductography, or galactography, is an imaging technique where a fine catheter is inserted into the discharging duct on the nipple, and a small amount of contrast material is injected to outline the ductal system on a mammogram. It was historically used to identify the location of intraductal lesions. However, the procedure can be technically challenging and uncomfortable for the patient. It has largely been superseded by high-resolution breast ultrasound and, in select cases, breast MRI, which are non-invasive or less invasive and can often identify and characterize intraductal pathology more effectively.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — June 27, 2026